Michelle J. Versleijen
Amsterdam, NH, Netherlands
Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 10 publications
Extravasation After [ 177 Lu]Lu-HA-DOTATATE Therapy.
Journal: Clinical nuclear medicine
Published: March 11, 2024
Extrahepatic perfusion and incomplete hepatic perfusion after hepatic arterial infusion pump implantation: incidence and clinical implications.
Journal: HPB : the official journal of the International Hepato Pancreato Biliary Association
Published: September 08, 2023
Post-PRRT scans: which scans to make and what to look for.
Journal: Cancer imaging : the official publication of the International Cancer Imaging Society
Published: February 07, 2022
Discordant Uptake Between Diagnostic 68Ga-HA-DOTATATE PET/CT and Posttherapy 177Lu-HA-DOTATATE SPECT/CT in Patients With Neuroendocrine Tumors.
Journal: Clinical nuclear medicine
Published: March 30, 2021
Haematotoxicity during peptide receptor radionuclide therapy: Baseline parameters differences and effect on patient's therapy course.
Journal: PloS one
Published: March 02, 2021
F-18 Fluorodeoxyglucose Positron Emission Tomography with Computed Tomography Has High Diagnostic Value for Pelvic and Distant Staging in Patients with High-risk Penile Carcinoma.
Journal: European urology focus
Published: November 22, 2020
Early response assessment and prediction of overall survival after peptide receptor radionuclide therapy.
Journal: Cancer imaging : the official publication of the International Cancer Imaging Society
Published: May 14, 2020
A head-to-head comparison between two commercial software packages for hybrid dosimetry after peptide receptor radionuclide therapy.
Journal: EJNMMI physics
Published: December 12, 2019
Adjuvant Hepatic Arterial Infusion Pump Chemotherapy After Resection of Colorectal Liver Metastases: Results of a Safety and Feasibility Study in The Netherlands.
Journal: Annals of surgical oncology
Published: August 12, 2019
Avastin scintigraphy in surveillance of bevacizumab treatment in a patient with neurofibromatosis type 2: a case report.
Journal: Clinical nuclear medicine
Published: January 22, 2014
Showing 1-10 of 10
Last Updated: 09/26/2026